TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 47 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $22,108,000 | +1.7% | 22,235,000 | 0.0% | 0.34% | -23.0% |
| Q3 2020 | $21,742,000 | -36.1% | 22,235,000 | -36.0% | 0.45% | -47.2% |
| Q2 2020 | $34,018,000 | +5.7% | 34,735,000 | 0.0% | 0.85% | -43.6% |
| Q1 2020 | $32,172,000 | -98.6% | 34,735,000 | +43.3% | 1.50% | -60.4% |
| Q4 2019 | $2,314,443,000 | – | 24,235,000 | – | 3.79% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ZAZOVE ASSOCIATES LLC | 83,413,000 | $130,650,000 | 6.13% |
| AEGON USA Investment Management, LLC | 6,000,000 | $9,368,000 | 2.35% |
| MACKAY SHIELDS LLC | 24,370,000 | $38,152,000 | 2.07% |
| INCOME RESEARCH & MANAGEMENT | 4,374,000 | $6,829,000 | 1.11% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 20,000 | $20,347,000 | 0.99% |
| SHENKMAN CAPITAL MANAGEMENT INC | 5,269,000 | $8,264,000 | 0.82% |
| Mitsubishi UFJ Securities Holdings Co., Ltd. | 325,000 | $511,000 | 0.76% |
| PALISADE CAPITAL MANAGEMENT, LP | 9,299,000 | $14,598,000 | 0.47% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 14,543,000 | $23,021,000 | 0.35% |
| CSS LLC/IL | 3,750,000 | $5,893,000 | 0.35% |